TLR7 expression, survival prognosis, gene mutation, MMR, MSI, TMB, tumor immune microenvironment, functional pathways, and drug sensitivity were all demonstrated in a pan-cancer analysis. The gene discussed is TLR7; the disease is neoplasm.